DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

Recruiting now · Phase 2

Conditions studied: Cancer of the Breast, Chemotherapy-induced Neuropathy

In brief

Up to 80% of breast cancer survivors experience chemotherapy-induced neuropathy that impairs quality of life and increases fall risk long into survivorship, yet treatment options for neuropathy remain limited. The successful treatment will target neurophysiologic mechanisms for restoring function while addressing patient-reported symptoms and participation in treatment. Toward this end, the investigators propose to study a noninvasive, social sensorimotor intervention - Adapted Argentine Tango - which targets motor control restoration, symptom alleviation, and treatment participation in concert.

Key facts

Study ID
NCT06749210
Run by
Ohio State University Comprehensive Cancer Center
People needed
140
Starts
2025-02-19
Expected to finish
2029-08-15
Last updated by the study team
2025-11-05

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.